1␣,25(OH) 2 D 3 is an important negative regulator of parathyroid hormone (PTH) gene transcription. In parathyroid cells, as in other target tissues, 1␣,25(OH) 2 D 3 is degraded by side chain oxidation by the inducible 24-hydroxylase. We have previously shown that one metabolite of this pathway, 1␣,
Natural metabolites of 1α,25-dihydroxyvitamin D3 retain biologic activity mediated through the vitamin D receptor
✍ Scribed by H. Harant; D. Spinner; G.S. Reddy; I.J.D. Lindley
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 232 KB
- Volume
- 78
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
✦ Synopsis
1␣,25-dihydroxyvitamin D 3 (1␣,25(OH) 2 D 3 ), the active metabolite of vitamin D, mediates many of its effects through the intranuclear vitamin D receptor (VDR, NR1I1), that belongs to the large superfamily of nuclear receptors. Vitamin D receptor can directly regulate gene expression by binding to vitamin D response elements (VDREs) located in promoter or enhancer regions of various genes. Although numerous synthetic analogs of 1␣,25(OH) 2 D 3 have been analysed for VDR binding and transactivation of VDRE-driven gene expression, the biologic activity of many naturally occuring metabolites has not yet been analyzed in detail. We therefore studied the transactivation properties of 1␣,24R,25-trihydroxyvitamin D 3 (1␣,24R,25(OH) 3 D 3 ), 1␣,25-dihydroxy-3-epi-vitamin D 3 (1␣,25(OH) 2 -3-epi-D 3 ), 1␣,23S,25-trihydroxyvitamin D 3 (1␣,23S,25(OH) 3 D 3 ), and 1␣-hydroxy-23-carboxy-24,25,26,27-tetranorvitamin D 3 (1␣(OH)-24,25,26,27-tetranor-23-COOH-D 3 ; calcitroic acid) using the human G-361 melanoma cell line. Cells were cotransfected with a VDR expression plasmid and luciferase reporter gene constructs driven by two copies of the VDRE of either the mouse osteopontin promoter or the 1␣,25(OH) 2 D 3 24-hydroxylase (CYP24) promoter. Treatment with 1␣,25(OH) 2 D 3 or the metabolites 1␣,24R,25(OH) 3 D 3 , 1␣,25(OH) 2 -3-epi-D 3 , and 1␣,23S,25(OH) 3 D 3 resulted in transactivation of both constructs in a time-and dose-dependent manner, and a postitive regulatory effect was observed even for calcitroic acid in the presence of overexpressed VDR. The metabolites that were active in the reporter gene assay also induced expression of CYP24 mRNA in the human keratinocyte cell line HaCaT, although with less potency than the parent hormone. A ligand-binding assay based on nuclear extracts from COS-1 cells overexpressing human VDR demonstrated that the metabolites, although active in the reporter gene assay, were much less effective in displacing [ 3 H]-labeled 1␣,25(OH) 2 D 3 from VDR than the parent hormone. Thus, we report that several natural metabolites of 1␣,25(OH) 2 D 3 retain significant biologic activity mediated through VDR despite their apparent low affinity for VDR.
📜 SIMILAR VOLUMES
1␣,25-Dihydroxyvitamin D 3 has been shown to exert its effects by both genomic (minutes to hours) and rapid (seconds to minutes) mechanisms. The genomic effects are mediated by interaction with the nuclear vitamin D receptor. We show that the vitamin D analog, [ 14 C]-1␣,25-dihydroxyvitamin D 3 brom
## Abstract Treatment with 10^−8^ m 1,25‐dihydroxyvitamin D~3~ for 24 h causes transcriptional activation of the human insulin receptor gene in U‐937 human promonocytic cells. The activation seems to potentiate the response to insulin in terms of glucose oxidation. Wortmannin, a phosphatidylinosito
Copper-Mediated Alkylation of Vitamin D C-Ring. Synthesis of C11-Functionalized 1α,25-Dihydroxyvitamin D3. -The functionalization of C-11 of CD-ring fragments of vitamin D3, e.g. (I), with organocopper reagents is studied. The application results in an efficient, convergent synthesis of the calcitr